Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 341

1.

Reprimo as a potential biomarker for early detection in gastric cancer.

Bernal C, Aguayo F, Villarroel C, Vargas M, Díaz I, Ossandon FJ, Santibáñez E, Palma M, Aravena E, Barrientos C, Corvalan AH.

Clin Cancer Res. 2008 Oct 1;14(19):6264-9. doi: 10.1158/1078-0432.CCR-07-4522.

2.

DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis.

Bernal C, Vargas M, Ossandón F, Santibáñez E, Urrutia J, Luengo V, Zavala LF, Backhouse C, Palma M, Argandoña J, Aguayo F, Corvalán A.

Biol Res. 2008;41(3):303-15. doi: /S0716-97602008000300007. Epub 2009 Apr 23.

3.
4.

CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.

Chang MS, Uozaki H, Chong JM, Ushiku T, Sakuma K, Ishikawa S, Hino R, Barua RR, Iwasaki Y, Arai K, Fujii H, Nagai H, Fukayama M.

Clin Cancer Res. 2006 May 15;12(10):2995-3002.

5.

Profile of aberrant CpG island methylation along multistep gastric carcinogenesis.

Kang GH, Lee S, Kim JS, Jung HY.

Lab Invest. 2003 Apr;83(4):519-26. Erratum in: Lab Invest. 2003 Jul;83(7):1093.

PMID:
12695555
6.

Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.

Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ.

Hum Pathol. 2009 Nov;40(11):1534-42. doi: 10.1016/j.humpath.2009.01.029. Epub 2009 Aug 19.

PMID:
19695681
7.

Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer.

Leung WK, To KF, Chu ES, Chan MW, Bai AH, Ng EK, Chan FK, Sung JJ.

Br J Cancer. 2005 Jun 20;92(12):2190-4.

8.

Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma.

Jee CD, Kim MA, Jung EJ, Kim J, Kim WH.

Eur J Cancer. 2009 May;45(7):1282-93. doi: 10.1016/j.ejca.2008.12.027. Epub 2009 Feb 3.

PMID:
19195878
9.

[Hierarchical clustering analysis to detect associations between clinical and pathological features of gastric tumors and hypermethylation of suppressor genes].

Zavala G L, Luengo J V, Ossandón C F, Riquelme S E, Backhouse E C, Palma V M, Argandoña C J, Cumsille MA, Corvalán R A.

Rev Med Chil. 2007 Jan;135(1):17-25. Epub 2007 Mar 6. Spanish.

10.

Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer.

Lee BB, Lee EJ, Jung EH, Chun HK, Chang DK, Song SY, Park J, Kim DH.

Clin Cancer Res. 2009 Oct 1;15(19):6185-91. doi: 10.1158/1078-0432.CCR-09-0111. Epub 2009 Sep 22.

11.

[CpG island methylation of E-cadherin gene promoter in gastric carcinoma].

Zhou YN, Xu CP, Han B, Ji R.

Ai Zheng. 2005 Oct;24(10):1220-4. Chinese.

PMID:
16219136
12.

Tumor suppressor gene hypermethylation as a predictor of gastric stromal tumor behavior.

House MG, Guo M, Efron DT, Lillemoe KD, Cameron JL, Syphard JE, Hooker CM, Abraham SC, Montgomery EA, Herman JG, Brock MV.

J Gastrointest Surg. 2003 Dec;7(8):1004-14; discussion 1014.

PMID:
14675710
13.

Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.

Hoque MO, Topaloglu O, Begum S, Henrique R, Rosenbaum E, Van Criekinge W, Westra WH, Sidransky D.

J Clin Oncol. 2005 Sep 20;23(27):6569-75.

PMID:
16170165
14.

Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence.

Righini CA, de Fraipont F, Timsit JF, Faure C, Brambilla E, Reyt E, Favrot MC.

Clin Cancer Res. 2007 Feb 15;13(4):1179-85.

15.

Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer.

Topaloglu O, Hoque MO, Tokumaru Y, Lee J, Ratovitski E, Sidransky D, Moon CS.

Clin Cancer Res. 2004 Apr 1;10(7):2284-8.

16.

Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients.

Chan MW, Chan LW, Tang NL, Tong JH, Lo KW, Lee TL, Cheung HY, Wong WS, Chan PS, Lai FM, To KF.

Clin Cancer Res. 2002 Feb;8(2):464-70.

17.

[Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer].

Liu WT, Jiao HL, Yang YL, Wang D, Zhang WM.

Ai Zheng. 2007 Nov;26(11):1199-203. Chinese.

PMID:
17991318
18.

Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer.

Zhang Y, Wang R, Song H, Huang G, Yi J, Zheng Y, Wang J, Chen L.

Cancer Lett. 2011 Apr 1;303(1):21-8. doi: 10.1016/j.canlet.2010.12.011. Epub 2011 Jan 20.

PMID:
21255913
19.

Biological significance of promoter hypermethylation of tumor-related genes in patients with gastric carcinoma.

Ksiaa F, Ziadi S, Amara K, Korbi S, Trimeche M.

Clin Chim Acta. 2009 Jun 27;404(2):128-33. doi: 10.1016/j.cca.2009.03.044. Epub 2009 Mar 29.

PMID:
19336228
20.

CpG island promoter methylation (CIHM) status of tumor suppressor genes correlates with morphological appearances of gastric cancer.

Tahara T, Shibata T, Arisawa T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Yonemura J, Maeda Y, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Hirata I.

Anticancer Res. 2010 Jan;30(1):239-44.

PMID:
20150642

Supplemental Content

Support Center